Get unlimited digital access to baltimoresun.com. $0.99 for 4 weeks.
SCHOOL DELAYS

Amgen agrees to acquire Onyx

Robert A. Bradway, chairman and chief executive of Amgen Inc., reached a deal for Onyx Pharmaceuticals Inc. and its prized cancer drug, Kyprolis.

Matt Petit/Feature Photo Service
This photo is featured in these articles:
Loading